Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers
Cao Dai Phung(National University of Singapore), Minh T. N. Le(Agency for Science, Technology and Research)
Cited by 3
Related Papers
MicroRNA-125b is a novel negative regulator of p53
|Genes & Development|2009|648
Efficient RNA drug delivery using red blood cell extracellular vesicles
|Nature Communications|2018|642
Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery
|Journal of Extracellular Vesicles|2021|230
Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs
|PLoS Genetics|2011|109
microRNA exchange via extracellular vesicles in cancer
|Cell Proliferation|2020|56